- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07351344
African Survey on Sepsis Knowledge (ASK) (ASK)
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Claudia Spies, MD, Prof.
- Phone Number: +49 30 450 55 11 02
- Email: claudia.spies@charite.de
Study Locations
-
-
-
Kumasi, Ghana
- Recruiting
- The Komfo Anokye teaching hospital
-
Contact:
- Phone Number: +233 593 830 400
- Email: info@kath.gov.gh
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Occupation: adult members of a healthcare profession (e.g., doctors, nurses, midwifes) or their trainees
- Place of work: employment in a healthcare facility in one of the seven partner countries (Uganda, Ethiopia, Democratic Republic of the Congo, Mozambique, Ghana, Sierra Leone, Nigeria).
- Consent: Willingness to participate voluntarily in the anonymous online survey.
Exclusion Criteria:
- Not employed in a healthcare profession (e.g., administrative staff, non-medical professionals)
- Not employed in one of the participating countries. Incomplete questionnaires (< 50% of questions answered)
- No internet access or technical limitations that make participation impossible. To complete the survey online.
- Language skills: Sufficient language skills in the survey language (English or French)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Participants from the first wave
150 adult participants from healthcare professions from partner institutions in Uganda, Ethiopia, the Democratic Republic of Congo, Mozambique, Ghana, Sierra Leone, and Nigeria are surveyed.
|
|
Participants from the second wave
150 adult participants from healthcare professions from partner institutions in Uganda, Ethiopia, the Democratic Republic of Congo, Mozambique, Ghana, Sierra Leone, and Nigeria are surveyed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sepsis - Knowledge - Score
Time Frame: Baseline survey period (January 19, 2026 - April 30, 2026) and follow-up survey period (April 1, 2027 - July 31, 2027)
|
|
Baseline survey period (January 19, 2026 - April 30, 2026) and follow-up survey period (April 1, 2027 - July 31, 2027)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Domain-specific knowledge of sepsis
Time Frame: Baseline survey period (January 19, 2026 - April 30, 2026), and follow-up survey period (April 1, 2027 - July 31, 2027)
|
Domain-specific knowledge of sepsis is measured in five domains, to identify specific knowledge gaps. Domain-specific scores will be measured as the sum of correctly answered questions in the questionnaire in respective domain. Domains are:
All domains together sum up to the overall sepsis knowledge score (primary outcome). |
Baseline survey period (January 19, 2026 - April 30, 2026), and follow-up survey period (April 1, 2027 - July 31, 2027)
|
|
Analysis of sepsis knowledge scores and domain-specific scores by professional role
Time Frame: Baseline survey period (January 19, 2026 - April 30, 2026), and follow-up survey period (April 1, 2027 - July 31, 2027)
|
|
Baseline survey period (January 19, 2026 - April 30, 2026), and follow-up survey period (April 1, 2027 - July 31, 2027)
|
|
Country comparison
Time Frame: Baseline survey period (January 19, 2026 - April 30, 2026), and follow-up survey period (April 1, 2027 - July 31, 2027)
|
• Between group comparison in sepsis knowledge scores and domain-specific sepsis knowledge between different countries (Uganda, Ethiopia, the Demoratic Republic of the Congo, Mozambique, Ghana, Sierra Leone, Nigeria, (potentially other countries in case of spill-over).
|
Baseline survey period (January 19, 2026 - April 30, 2026), and follow-up survey period (April 1, 2027 - July 31, 2027)
|
|
Second survey wave only: Change in sepsis knowledge scores between survey waves
Time Frame: Follow-up survey period (April 1, 2027 - July 31, 2027)
|
- Difference in average knowledge score in repeated survey.
|
Follow-up survey period (April 1, 2027 - July 31, 2027)
|
|
Comparison of sepsis knowledge scores by self-reported participation in capacity-building measures
Time Frame: Follow-up survey period (April 1, 2027 - July 31, 2027)
|
|
Follow-up survey period (April 1, 2027 - July 31, 2027)
|
|
Baseline survey only: Self-assessment of perceived training needs
Time Frame: Baseline survey period (January 19, 2026 - April 30, 2026)
|
|
Baseline survey period (January 19, 2026 - April 30, 2026)
|
|
Vignette-based sepsis knowledge score (sum of correct responses to predefined vignette items)
Time Frame: Baseline survey period (January 19, 2026 - April 30, 2026), and follow-up survey period (April 1, 2027 - July 31, 2027)
|
|
Baseline survey period (January 19, 2026 - April 30, 2026), and follow-up survey period (April 1, 2027 - July 31, 2027)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Claudia Spies, MD, Prof., Department of Anesthesiology and Intensive Care Medicine (CCM/CVK), Charité - University Medicine Berlin
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STAIRS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of California, San FranciscoNational Cancer Institute (NCI)RecruitingSepsis | Sepsis, Severe | Sepsis and Septic Shock | Sepsis at Intensive Care Unit | Sepsis, Septic Shock | Sepsis, Severe Sepsis and Septic Shock | Sepsis With Multiple Organ Dysfunction (MOD) | Sepsis With Acute Organ DysfunctionUnited States
-
Assiut UniversityNot yet recruitingSepsis Induced Myocardial Dysfunction | Sepsis Induced CardiomyopathyEgypt
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityEnrolling by invitationSevere Sepsis | Severe Sepsis Without Septic ShockUnited States